NCT04568135 is a clinical trial of survey in Covid19, sponsored by Siyan Clinical Corporation.

Who is sponsoring NCT04568135?

NCT04568135 is sponsored by Siyan Clinical Corporation.

What drugs are being tested in NCT04568135?

Interventions in NCT04568135: survey.

Is NCT04568135 still recruiting?

NCT04568135 is currently status unknown. Last updated 14 October 2020.

Last reviewed 2020-10-14 · How we verify

NCT04568135

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Survey Study to Assess the Impact of the COVID-19 Pandemic on Participants With Pre-Existing Mental Health Diagnosis

Status unknown Last updated 14 October 2020

What this trial tests

trial testing survey in Covid19 in 1,000 participants. Status unknown.

Timeline

31 October 2020

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Siyan Clinical Corporation
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	31 October 2020
Primary completion	31 December 2021
Estimated completion	31 December 2021

Drugs / interventions tested

survey

Conditions studied

Covid19 — all drugs for Covid19 →

Sponsor

Siyan Clinical Corporation

Who can join

Adults 18 to 80, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this survey study is to assess the impact of the current COVID-19 pandemic on participants with psychiatric disorders to identify areas of needed support and services. Data collected may serve as a foundational research in the prevention, care and treatment of mental health disorders during pandemics such as COVID-19. This survey study will utilize the Epidemic-Pandemic Impacts Inventory (EPII). This is a newly tool designed to assess tangible impacts of epidemics and pandemics across personal and social life domains.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Measuring the Impact of COVID-19 on Siyan Mental Health Patients Using the Epidemic-Pandemic Impacts Inventory: Survey Study.
Shah A, Darling M, Arstein-Kerslake O, Morgan T, et al · · 2021 · cited 6× · PMID 34323851 · DOI 10.2196/29952
Latent class analysis of the Epidemic-Pandemic Impacts Inventory on mental health outcomes in Siyan Clinical patients.
Shah A, Arstein-Kerslake O, Darling M, Morgan T, et al · · 2023 · cited 2× · PMID 37091358 · DOI 10.1002/hsr2.1215

Verify or expand the search:

Other trials of survey

Trials testing the same drug.

NCT07340203 — Cross-Cultural Adaptation, Validity, and Reliability of the Wexner Questionnaire in Patients With Constipation · active not recruiting
NCT07033390 — Monitor Orthopaedic Footwear Questionnaire (MOS) Validity and Reliability Study · enrolling by invitation
NCT07012083 — Adherence to Anti-rabies Post-exposure Prophylactic Protocols · completed
NCT06897865 — Nursing Students Education Virtual Reality Wound Care · not yet recruiting
NCT06514443 — Barriers and Faciliators for Physical Activity in People With RMDs · not yet recruiting

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04568135 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Siyan Clinical Corporation
Last refreshed: 14 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04568135.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing